Likewise, an endogenous mouse neoantigen of very low affinity for MHC H2-Kd was also categorized as non-MHC I-binder and non-immunogenic, yet it was able to elicit CD8 T cell-dependent tumor rejection and protection (37). The gene discussed is CD8A; the disease is neoplasm.